241 related articles for article (PubMed ID: 26153642)
1. The indirect costs of systemic autoimmune diseases, systemic lupus erythematosus, systemic sclerosis and sarcoidosis: a summary of 2012 real-life data from the Social Insurance Institution in Poland.
Kawalec PP; Malinowski KP
Expert Rev Pharmacoecon Outcomes Res; 2015; 15(4):667-73. PubMed ID: 26153642
[TBL] [Abstract][Full Text] [Related]
2. Indirect costs of absenteeism due to rheumatoid arthritis, psoriasis, multiple sclerosis, insulin-dependent diabetes mellitus, and ulcerative colitis in 2012: a study based on real-life data from the Social Insurance Institution in Poland.
Malinowski KP; Kawalec PP; Moćko P
Expert Rev Pharmacoecon Outcomes Res; 2016; 16(2):295-303. PubMed ID: 26377953
[TBL] [Abstract][Full Text] [Related]
3. Health-Related Quality of Life Impairment and Indirect Cost of Crohn's Disease: A Self-Report Study in Poland.
Holko P; Kawalec P; Mossakowska M; Pilc A
PLoS One; 2016; 11(12):e0168586. PubMed ID: 27992531
[TBL] [Abstract][Full Text] [Related]
4. The indirect costs of cancer-related absenteeism in the workplace in Poland.
Macioch T; Hermanowski T
J Occup Environ Med; 2011 Dec; 53(12):1472-7. PubMed ID: 22045222
[TBL] [Abstract][Full Text] [Related]
5. Indirect costs and incidence of caregivers' short-term absenteeism in Poland, 2006-2016.
Łyszczarz B
BMC Public Health; 2019 May; 19(1):598. PubMed ID: 31101035
[TBL] [Abstract][Full Text] [Related]
6. Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts.
Jönsen A; Hjalte F; Willim M; Carlsson KS; Sjöwall C; Svenungsson E; Leonard D; Bengtsson C; Rantapää-Dahlqvist S; Pettersson S; Gunnarsson I; Zickert A; Gustafsson JT; Rönnblom L; Petersson IF; Bengtsson AA; Nived O
Semin Arthritis Rheum; 2016 Jun; 45(6):684-90. PubMed ID: 26743074
[TBL] [Abstract][Full Text] [Related]
7. Excess Productivity Costs of Systemic Lupus Erythematosus, Systemic Sclerosis, and Sjögren's Syndrome: A General Population-Based Study.
McCormick N; Marra CA; Sadatsafavi M; Kopec JA; Aviña-Zubieta JA
Arthritis Care Res (Hoboken); 2019 Jan; 71(1):142-154. PubMed ID: 29648677
[TBL] [Abstract][Full Text] [Related]
8. Direct and indirect costs to employers of patients with systemic lupus erythematosus with and without nephritis.
Carls G; Li T; Panopalis P; Wang S; Mell AG; Gibson TB; Goetzel RZ
J Occup Environ Med; 2009 Jan; 51(1):66-79. PubMed ID: 19136875
[TBL] [Abstract][Full Text] [Related]
9. [Cost of lost productivity in pharmacoeconomics analysis. Part I. A systematic review of the literature].
Wrona W; Hermanowski T; Golicki D; Jakubczyk M; Macioch T; Goszczyńska K; Wójcik R
Przegl Epidemiol; 2011; 65(1):147-52. PubMed ID: 21735852
[TBL] [Abstract][Full Text] [Related]
10. Disease activity, quality of life and indirect costs of psoriatic arthritis in Poland.
Kawalec P; Malinowski KP; Pilc A
Rheumatol Int; 2016 Sep; 36(9):1223-30. PubMed ID: 27339273
[TBL] [Abstract][Full Text] [Related]
11. Economic burden of systemic lupus erythematosus flares and comorbidities in a commercially insured population in the United States.
Narayanan S; Wilson K; Ogelsby A; Juneau P; Durden E
J Occup Environ Med; 2013 Nov; 55(11):1262-70. PubMed ID: 24202242
[TBL] [Abstract][Full Text] [Related]
12. Indirect costs and public finance consequences of heart failure in Poland, 2012-2015.
Łyszczarz B
BMC Public Health; 2018 Sep; 18(1):1130. PubMed ID: 30231932
[TBL] [Abstract][Full Text] [Related]
13. Social costs of loss in productivity-related absenteeism in Poland.
Genowska A; Fryc J; Pinkas J; Jamiołkowski J; Szafraniec K; Szpak A; Bojar I
Int J Occup Med Environ Health; 2017 Oct; 30(6):917-932. PubMed ID: 28584315
[TBL] [Abstract][Full Text] [Related]
14. The Direct and Indirect Costs of Breast Cancer in Poland: Estimates for 2017-2019.
Seweryn M; Banas T; Augustynska J; Lorenc O; Kopel J; Pluta E; Skora T
Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554267
[TBL] [Abstract][Full Text] [Related]
15. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany.
Huscher D; Merkesdal S; Thiele K; Zeidler H; Schneider M; Zink A;
Ann Rheum Dis; 2006 Sep; 65(9):1175-83. PubMed ID: 16540552
[TBL] [Abstract][Full Text] [Related]
16. [Productivity costs of rheumatoid arthritis in Germany. Cost composition and prediction of main cost components].
Merkesdal S; Huelsemann JL; Mittendorf T; Zeh S; Zeidler H; Ruof J
Z Rheumatol; 2006 Oct; 65(6):527-34. PubMed ID: 16534538
[TBL] [Abstract][Full Text] [Related]
17. Productivity losses and public finance burden attributable to breast cancer in Poland, 2010-2014.
Łyszczarz B; Nojszewska E
BMC Cancer; 2017 Oct; 17(1):676. PubMed ID: 29017454
[TBL] [Abstract][Full Text] [Related]
18. Cost-of-illness studies in systemic lupus erythematosus: A systematic review.
Zhu TY; Tam LS; Li EK
Arthritis Care Res (Hoboken); 2011 May; 63(5):751-60. PubMed ID: 21557530
[TBL] [Abstract][Full Text] [Related]
19. Productivity Losses and Costs in the Less-Common Systemic Autoimmune Rheumatic Diseases.
McCormick N; Marra CA; Aviña-Zubieta JA
Curr Rheumatol Rep; 2017 Oct; 19(11):72. PubMed ID: 29086172
[TBL] [Abstract][Full Text] [Related]
20. Disease activity, quality of life and indirect costs of reduced productivity at work, generated by Polish patients with ankylosing spondylitis.
Kawalec P; Malinowski K
Reumatologia; 2015; 53(6):301-8. PubMed ID: 27407262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
